Blue Dot News

One story a day from the frontier of human knowledge.

Physics ·

Physics

New enzyme helps protect heart during heart attacks

A team of researchers found that a key enzyme, GPX4, can reduce damage to the heart muscle and improve its function after a heart attack by promoting the removal of damaged mitochondria.

Illustration: Blue Dot News

1 min read

In the depths of our own hearts, where oxygen and nutrients flow like rivers, lies a tiny guardian that watches over the delicate balance of life. This sentinel is GPX4, a ferroptosis regulator whose role was long shrouded in mystery. For years, researchers have wondered how GPX4 behaves during myocardial ischemia/reperfusion injury, or heart attack and subsequent restoration of blood flow.

A team led by Zhong L uncovered the truth behind GPX4's actions, and what they found is nothing short of remarkable. When hearts are subjected to the stress of a heart attack, GPX4 levels rise in bordering areas but plummet in the ischemic region – the area directly affected by the blockage. This disparity suggests that GPX4 plays a crucial role in mitigating damage to the heart's inner workings during an attack.

It turns out that GPX4 does this by stabilizing a protein called BNIP3, which is responsible for clearing damaged mitochondria through a process called mitophagy. By keeping BNIP3 intact, GPX4 helps preserve mitochondrial function and ultimately saves the heart from long-term damage. This discovery not only sheds light on a previously unknown mechanism of ferroptosis but also offers new hope for treating cardiovascular disease, where millions of lives are at stake.

The people behind the work

  • Zhong L et al.

    Author

    Published in Nature communications

Source: Nature communications

Sources & Verification

Every statement in this story is drawn from the facts below. Each is linked to a primary or reputable source — follow any citation to check it for yourself.

  1. GPX4 is a crucial regulator of ferroptosis, yet its role in mitochondrial dysfunction during myocardial ischemia/reperfusion injury (MI/RI) is unclear. Nature communications
  2. This study aims to clarify the effect and molecular mechanisms of GPX4 in MI/RI. Nature communications
  3. We analyzed the spatiotemporal dynamics of GPX4 during MI/RI and observed high expression levels in border and normal areas but a significant reduction in the ischemic region utilizing spatial transcriptomics, spatial proteomics, and single-cell sequencing. Nature communications
  4. Cardiomyocyte-derived GPX4 notably reduces myocardial damage and mitochondrial dysfunction in MI/RI while also alleviating long-term ventricular remodeling. Nature communications
  5. Mechanistically, our findings reveal that GPX4, through its critical U46 active site, enhances the interaction between BNIP3 and USP20, decreasing ubiquitination at K131 of BNIP3. Nature communications
  6. This process stabilizes BNIP3, promotes mitophagy, improves mitochondrial function, and ultimately preserves cardiac function. Nature communications
  7. Our research defines the role of the GPX4/BNIP3/USP20 complex in MI/RI and uncovers a mechanism linking GPX4 to ferroptosis-related mitochondrial damage, providing valuable insights for advancing ferroptosis studies. Nature communications

Part of the Blue Dot News 2026 retrospective — an archive reconstructed automatically from the published scientific record. The science is real and cited above; this is not original daily reporting, and it is deliberately kept out of the live news feed.

← All stories